Otelfingen, Switzerland

Aureliano Zana

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Philochem Ag. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aureliano Zana. Retrieved from https://idiyas.com/inventor/aureliano-zana

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aureliano Zana: Innovator in Targeted Delivery Applications

Introduction

Aureliano Zana is an inventor based in Otelfingen, Switzerland. He has made significant contributions to the field of targeted delivery applications, particularly in the development of ligands for Fibroblast Activation Protein (FAP). His work focuses on creating innovative solutions for the active delivery of therapeutic agents to specific sites of disease.

Latest Patent Applications

Aureliano Zana has filed several patent applications, including:

1. **CONJUGATES OF PSMA-BINDING MOIETIES WITH CYTOTOXIC AGENTS** - This application describes a conjugate that includes a PSMA binding moiety linked to a cytotoxic agent through a linker. The linker is designed to facilitate the delivery of the drug to targeted cells.

2. **HIGH-AFFINITY LIGANDS OF FIBROBLAST ACTIVATION PROTEIN FOR TARGETED DELIVERY APPLICATIONS** - This invention relates to ligands that enhance the delivery of various payloads, such as cytotoxic drugs and immunomodulators, specifically targeting areas characterized by the overexpression of FAP.

Conclusion

Aureliano Zana is an innovative inventor whose work in targeted delivery applications holds promise for advancing therapeutic strategies in treating diseases like cancer. His latest patent applications reflect his commitment to developing effective solutions in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…